CompoAtlas

Multivitamines

Food supplement declared in France, decision dated 29 October 2026

Multivitamines (VITAVEA) is a food supplement declared in France. Status: declared in France, may be marketed. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
VITAVEA
Food business operator placing the product on the market
HAVEA COMMERCIAL SERVICES
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Tablet
Daily dose
1 comprimé
Directions for use
Avaler avec un verre d'eau
Intended populations
Men and women aged 18 and over
Not recommended (according to the manufacturer)
Adolescents (moins de 18 ans), Autre : Fatigue, Enfants (moins de 12 ans), Enfants en bas âge (1 à 3 ans), Femmes enceintes, Nourrissons (moins de 1 an), Sous traitement médicamenteux, Utilisation prolongée, Enfants (de moins de 6 ans), Enfants (de moins de 10 ans)
Objectives stated by the manufacturer (these are not authorised claims)
Autre : Fatigue, Immunité

Declaration 380659, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Other active ingredients

NamePer day
Lysinenot declared
Tryptophanenot declared
L-Glutaminenot declared
Méthioninenot declared

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
D-pantothénate de calciumAcide pantothénique (vitamine B5)pas de limite (données insuffisantes)dose annulled by the French Council of State in 2011
D-biotineBiotine (vitamine B8)pas de limite (données insuffisantes)dose annulled by the French Council of State in 2011
Picolinate de chromeChromepas de limite (données insuffisantes)25 µg
Citrate de cuivreCuivre5,000 µg2,000 µg
Bisglycinate ferreuxFer40 mg (safe level)14 mg
Acide ptéroylmonoglutamiqueFolates (vitamine B9)1,000 µg200 µg
Iodure de potassiumIode600 µg150 µg
Oxyde de magnésiumMagnésium250 mg300 mg
Sulfate de manganèseManganèse8 mg (safe level)3.5 mg
Molybdate de sodiumMolybdène600 µg150 µg
NicotinamideNicotinamide (vitamine B3)900 mg54 mg
Levure enrichie en séléniumSélénium255 µg50 µg
Acétate de rétinyleVitamine A3,000 µg d'équivalent rétinol800 µg
Chlorhydrate de thiamineVitamine B1 (thiamine)pas de limite (données insuffisantes)dose annulled by the French Council of State in 2011
CyanocobalamineVitamine B12pas d'effet indésirable définidose annulled by the French Council of State in 2011
RiboflavineVitamine B2 (riboflavine)pas de limite (données insuffisantes)dose annulled by the French Council of State in 2011
Chlorhydrate de pyridoxineVitamine B612 mg2 mg
Acide L-ascorbiqueVitamine Cpas de limite (données insuffisantes)180 mg
CholécalciférolVitamine D100 µg (4,000 UI)5 µg (200 UI)
Acétate de DL-alpha-tocophéryleVitamine E300 mg30 mg
Oxyde de zincZinc25 mg15 mg

Additives

E420, E470b

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Has the product changed? Photograph the packaging.

Label warnings

Ne pas dépasser la dose journalière recommandée. A consommer dans le cadre d'une alimentation variée et équilibrée et d'un mode de vie sain. Garder hors de portée des enfants. Réservé à l'adulte. Déconseillé aux femmes enceintes ou désireuses de l'être, en cas de pathologie, situation médicale particulière ou traitement médicamenteux, de consommer d'autres compléments alimentaires contenant du zinc ou en usage prolongé. Ne pas utiliser de compléments alimentaires contenant du fer sans un avis médical pour les hommes et les femmes ménopausées. Une consommation incontrôlée en vitamine E peut augmenter le risque de cancer de la prostate chez les hommes âgées de 55 ans et plus. Informer le médecin ou le personnel de laboratoire en cas de prise récente de biotine avant un test de laboratoire. Une consommation excessive peut avoir des effets laxatifs. A conserver dans un endroit sec et frais.

Regulatory points

None of the rules we check applies to the declared ingredients.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Lysine
    Read the warning, when it applies and the studies cited

    LYSINE

    Route of administration: Oral

    Cautions and warnings

    Applies to products providing more than 300 mg of lysine, per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Goldman and Ausiello 2004).

    Sources cited by Health Canada (1)
    • Goldman L, Ausiello D, editors. Cecil Textbook of Medicine, Volume 1, 22nd edition. Philadelphia (PA): Saunders; 2004.

    Health Canada monograph dated 19 December 2025

  • L-Glutamine
    Read the warning, when it applies and the studies cited

    L-Glutamine

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Health Canada monograph dated 30 January 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Other declarations with the same name

This name is used by more than 10 declarations from different companies, so it does not identify one product. See every declaration with this name.

Brand : VITAVEA

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line